The CLYNAV brand, founded in 2011 (Switzerland), from 2951 sister brands and 17477 competing brands. CLYNAV is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. CLYNAV belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CLYNAV)
over 5 years*
CHF 101.45